We develop proprietary drugs in oncology, diabetology and pain utilizing unique formulations and drug delivery technologies


BIOTTS S.A., a Polish-American biotech company, develops proprietary drugs in oncology, diabetology, and pain utilizing unique formulations and drug delivery technologies. Biotts scientists have developed a breakthrough technology of universal transdermal therapeutic system MTC-Y (Multifunctional Transdermal Carrier-Y). The properties of the carrier increase the bioavailability of active substances several times, enabling them to penetrate through the skin into soft tissues and bones. The carrier can be easily modified to obtain targeted action in pathologically changed tissues. Thanks to the system, it is possible to reduce the therapeutic dose of the drug while maintaining its original effect and simultaneously reducing the side effects. In addition, the system enables the transport of one to several active substances, which makes it possible to design multi-component drugs.

How does transdermal Biotts technology work:

Biotts scientists, with more than three decades of experience, develop proprietary drugs and transdermal systems, solve complex technological problems, and create effective solutions to help people around the world.

We have provided the market with a variety of solutions, including: non-aggregating nanocarrier used in the production of vitamin preparations, therapeutic gels, semi-solid forms of the drug: with a carrier of deep penetration and accelerating tissue regeneration.

A revolution in drug delivery


19 December 2022

GIF has granted Biotts a license to manufacture and import a medicinal product

It’s official: Biotts has reached another important milestone in its development! The Chief Pharmaceutical Inspectorate (Główny Inspektorat ...


09 December 2022

The 5th Forum of Modern Diabetology and an award for Biotts

The 5 Forum Nowoczesnej Diabetologii (5th Forum of Modern Diabetology) has ended. One of the event’s highlights was a contest that featured the ...


08 December 2022

Dolnośląski Bon na Innowacje for Biotts

We’re excited to let you know about another big “win” for Biotts: The Lower Silesia Voucher for Innovation will allow for the further development ...


09 November 2022

Biotts at CPHI Frankfurt

CPHI Frankfurt – the event that brings together pharmaceutical professionals from around the world – has ended. Over the past few days Pawel ...



ul. Wrocławska 44c
55-040 Bielany Wrocławskie
+48 606 569 746

Biotts INC. office Boston Location

265 Franklin Street
Boston, MA 02110
(617) 9151350

Co-development partners